Breaking News
Investing Pro 0
👀 Bezos, Buffett & Berkowitz: What's in Their Portfolios? Unlock Data
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
72.62 +1.32    +1.85%
02/06 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
S/N:  885823
  • Volume: 2,326
  • Bid/Ask: 72.62 / 72.68
  • Day's Range: 70.42 - 72.62
Gilead 72.62 +1.32 +1.85%

Gilead Sciences Inc Company Profile

 
Get an in-depth profile of Gilead Sciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

14400

Equity Type

ORD

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, and Stribild. The Company’s COVID-19 product is Veklury. The Company’s also provides Epclusa, Harvoni, Vemlidy, and Viread products for liver diseases. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The Company’s other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.

Contact Information

Address 333 Lakeside Drive
Foster City, 94404
United States
Phone 650 574 3000
Fax 650 522 5853

Top Executives

Name Age Since Title
Eugene R. Schiff - - Member of the Scientific Advisory Board
Jacqueline K. Barton 68 1989 Independent Director
Paul E. Klotman - - Member of the Scientific Advisory Board
John W. Mellors 83 - Member of the Scientific Advisory Board
Francis V. Chisari - - Member of the Scientific Advisory Board
Sandra J. Horning 72 2020 Independent Director
Mark C. Genovese - - Member of Scientific Advisory Board
Daniel P. O'Day 57 2019 Chairman & CEO
Harish M. Manwani 68 2018 Independent Director
Malcolm MacCoss 73 - Member of Scientific Advisory Board
Nezam H. Afdhal 64 - Member of Scientific Advisory Board
Robert A. Harrington - - Member of the Scientific Advisory Board
Kevin E. Lofton 66 2009 Lead Independent Director
Paul Berg 94 1998 Member of Scientific Advisory Board
Kelly A. Kramer 53 2016 Independent Director
Eric J. Topol 67 - Member of Scientific Advisory Board
Robert T. Schooley - - Member of the Scientific Advisory Board
Kenneth C. Anderson 70 - Member of the Scientific Advisory Board
Brian J. Druker 66 - Member of the Scientific Advisory Board
Joel R. Huff - - Chairperson of Scientific Advisory Board
Javier J. Rodriguez 50 2020 Independent Director
Jeffrey A. Bluestone 68 2020 Independent Director
Anthony Welters 66 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email